EncounterCare Solutions, Inc.
OTC:ECSL
0.66 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.213 | 0.101 | 0.139 | 0.049 | 0.164 | 0.131 | 0.08 | 0.089 | 0.091 | 0.117 | 0.091 | 0.095 | 0.12 |
| Cost of Revenue
| 0.173 | 0.152 | 0.144 | 0.108 | 0.137 | 0.118 | 0.13 | 0.132 | 0.151 | 0.195 | 0.137 | 0.176 | 0.134 |
| Gross Profit
| 0.04 | -0.05 | -0.005 | -0.059 | 0.028 | 0.013 | -0.05 | -0.043 | -0.06 | -0.078 | -0.047 | -0.081 | -0.014 |
| Gross Profit Ratio
| 0.186 | -0.497 | -0.035 | -1.217 | 0.168 | 0.102 | -0.634 | -0.476 | -0.651 | -0.669 | -0.514 | -0.856 | -0.119 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.422 | 0.098 | 0.208 | 0.317 | 0.777 | 0.142 | 0.512 | 0.499 | 2.624 | 0.375 | 0.488 | 0.267 | 0.449 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 0.422 | 0.098 | 0.208 | 0.319 | 0.777 | 0.142 | 0.512 | 0.499 | 2.624 | 0.375 | 0.488 | 0.267 | 0.449 |
| Operating Income
| -0.382 | -0.148 | -0.213 | -0.378 | -0.749 | -0.129 | -0.563 | -0.542 | -2.683 | -0.453 | -0.535 | -0.347 | -0.463 |
| Operating Income Ratio
| -1.798 | -1.465 | -1.525 | -7.789 | -4.557 | -0.982 | -7.068 | -6.07 | -29.352 | -3.873 | -5.9 | -3.673 | -3.872 |
| Total Other Income Expenses Net
| -0.554 | -0.027 | -0.027 | -0.032 | -0.024 | -0.04 | -0.032 | -0.032 | -0.032 | -0.055 | -0.008 | -0.031 | -0.039 |
| Income Before Tax
| -0.937 | -0.175 | -0.239 | -0.41 | -0.773 | -0.169 | -0.595 | -0.573 | -2.715 | -0.508 | -0.543 | -0.379 | -0.502 |
| Income Before Tax Ratio
| -4.406 | -1.729 | -1.717 | -8.443 | -4.7 | -1.287 | -7.466 | -6.426 | -29.7 | -4.344 | -5.993 | -4.006 | -4.202 |
| Income Tax Expense
| 0 | -0.122 | -0.042 | -0.055 | -0.027 | -0.086 | -0.06 | -0.071 | -0.054 | -0.056 | -0.055 | -0.055 | -0.053 |
| Net Income
| -0.937 | -0.175 | -0.239 | -0.41 | -0.773 | -0.169 | -0.595 | -0.573 | -2.715 | -0.508 | -0.543 | -0.379 | -0.502 |
| Net Income Ratio
| -4.406 | -1.729 | -1.717 | -8.443 | -4.7 | -1.287 | -7.466 | -6.426 | -29.7 | -4.344 | -5.993 | -4.006 | -4.202 |
| EPS
| -0.011 | -0.002 | -0.003 | -0.005 | -0.009 | -0.002 | -0.007 | -0.007 | -0.033 | -0.007 | -0.007 | -0.005 | -0.007 |
| EPS Diluted
| -0.011 | -0.002 | -0.003 | -0.005 | -0.009 | -0.002 | -0.007 | -0.007 | -0.033 | -0.007 | -0.007 | -0.005 | -0.007 |
| EBITDA
| -0.363 | -0.148 | -0.213 | -0.378 | -0.749 | -0.129 | -0.563 | -0.542 | -2.683 | -0.453 | -0.535 | -0.347 | -0.463 |
| EBITDA Ratio
| -1.709 | -1.465 | -1.525 | -7.789 | -4.557 | -0.982 | -7.068 | -6.07 | -29.352 | -3.873 | -5.9 | -3.673 | -3.872 |